|Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany.|
|PMID: 19693509 Owner: NLM Status: MEDLINE|
|PURPOSE: To evaluate treatment outcomes and resource consumption of patients with neurogenic detrusor overactivity (NDO) before and after botulinum toxin A (Botox) therapy in Germany. METHODS: In a multi-center, cross-sectional, retrospective cohort study, data of patients with NDO 12 months before and after the first Botox therapy were analyzed. RESULTS: 214 patients (mean age 38 +/- 14.8 years, 145 male, 69 female) with NDO due to spinal cord injury (81%); myelomeningocele (14%), or Multiple Sclerosis (5%) from seven hospitals were included. Mean interval between treatments was 8 months. Following treatment, mean maximum detrusor pressure, maximum cystometric capacity and detrusor compliance improved significantly. Prior to Botox therapy, 68% reported urinary tract infections (UTI), 63% had incontinence episodes, and 58% used incontinence aids. These numbers decreased significantly (p < 0.05) after treatment to 28, 33, and 28%, respectively. In patients using incontinence aids, mean costs per patient decreased from 2euro to 1euro per day, whereas the mean cost of drugs to treat UTIs per patient decreased from 163euro to 80euro per year, respectively. CONCLUSION: This is the first study demonstrating the clinical usefulness of Botox therapy in clinical practice. Successful treatment resulted in lower costs for NDO associated morbidity due to less need for incontinence aids and UTI medication.|
|Björn Wefer; Birgit Ehlken; Jörn Bremer; Harald Burgdörfer; Burkhard Domurath; Christian Hampel; Johannes Kutzenberger; Christoph Seif; Karl D Sievert; Karin Berger; Jürgen Pannek|
Related Documents :
|11114559 - Transvaginal therapy of genuine stress incontinence.
8911369 - Post-prostatectomy incontinence and the artificial urinary sphincter: a long-term study...
7441829 - Ams 742 sphincter: ucla experience.
9834889 - Effectiveness in learning complex problem solving and salivary ion indices of psycholog...
17327249 - Non-surgical management of stress urinary incontinence: ambulatory treatments for leaka...
19843119 - Sacral nerve stimulation for the treatment of faecal incontinence following low anterio...
2123079 - Long-term predictors of outcome in abstinent alcoholic men.
24574019 - A prospective study of one-year clinical outcomes utilizing a composite three-dimension...
24820389 - Peratrial device closure of perimembranous ventricular septal defects through a right p...
|Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't Date: 2009-08-20|
|Title: World journal of urology Volume: 28 ISSN: 1433-8726 ISO Abbreviation: World J Urol Publication Date: 2010 Jun|
|Created Date: 2010-05-21 Completed Date: 2010-08-24 Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 8307716 Medline TA: World J Urol Country: Germany|
|Languages: eng Pagination: 385-90 Citation Subset: IM|
|Klinik für Urologie und Kinderurologie, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.|
|APA/MLA Format Download EndNote Download BibTex|
Botulinum Toxin Type A / economics, therapeutic use*
Cost of Illness*
Dose-Response Relationship, Drug
Drug Administration Schedule
Meningomyelocele / complications
Multiple Sclerosis / complications
Quality of Life
Severity of Illness Index
Spinal Cord Injuries / complications
Urinary Bladder, Neurogenic / diagnosis, drug therapy*, economics, etiology
Urinary Bladder, Overactive / diagnosis, drug therapy*, economics*, etiology
|0/Botulinum Toxin Type A|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Efficacy of EMG-biofeedback in knee osteoarthritis.
Next Document: Technical options and prospects for telemedical devices in ophthalmology